Cytogenetic studies in myeloma.
نویسندگان
چکیده
Chromosomes have been studied in cultures of nucleated peripheral blood cells in 30 patients with myeloma. Both unstimulated cultures and cultures stimulated by phytohemagglutinin (PHA) were examined in all cases. Mitoses were observed in 13 unstimulated cultures of peripheral blood from 12 cases, providing evidence for the presence of circulating abnormal cells in these patients. In 19 stimulated cultures of peripheral blood from 17 cases, abnormal mitoses were present, seven of these included abnormalities involving a chromosome of group 13-15. In five cases, a large acrocentric chromosome was observed similar to that previously described in some cases of myeloma. In eight cases, chromosome studies were also carried out on bone marrow to allow comparison of methods. Examination of stimulated peripheral blood cells was found to be the better method. Marked aneuploidy was not a feature of the results. No correlation was found between the cytogenetic abnormalities and previous treatment, disease stage, further progression of the disease, or serum and urinary protein abnormalities. The results are discussed, particularly with reference to technical factors influencing the frequency of demonstrable chromosome abnormalities in these cases and the relative merits of examination of peripheral blood and bone marrow.
منابع مشابه
Cytogenetics and Revised International Staging System (R-ISS): Risk Stratification in Multiple myeloma - A Retrospective Study in Indian Population
Background & Objective: Cytogenetic abnormalities in Multiple myeloma (MM) has emerged as the most important factor that determine the prognosis and survival. Fluorescence in situ hybridization (FISH) can detect a greater number of cytogenetic abnormalities as compared to conventional karyotyping and hence has become the standard test in determining genetic abnormalities in MM....
متن کاملCytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
Cytogenetic studies in clonal plasma cell disorders have mainly been done in whole bone marrow or CD138(+) microbead-enriched plasma cells and suggest that recurrent immunoglobulin heavy chain translocations - e.g. t(4;14) -are primary oncogenetic events. The aim of this study was to determine cytogenetic patterns of highly purified aberrant plasma cells (median purity ≥ 98%) in different clona...
متن کاملInterpretation of cytogenetic results in multiple myeloma for clinical practice
The interpretation of cytogenetic abnormalities in multiple myeloma (MM) is often a challenging task. MM is characterized by several cytogenetic abnormalities that occur at various time points in the disease course. The interpretation of cytogenetic results in MM is complicated by the number and complexity of the abnormalities, the methods used to detect them and the disease stage at which they...
متن کاملCT-guided biopsy of focal lesions in patients with multiple myeloma may reveal new and more aggressive cytogenetic abnormalities.
BACKGROUND AND PURPOSE Cytogenetic abnormalities, especially chromosome 13 deletion, are high-risk factors for multiple myeloma. Attaining the highest detection rates of cytogenetic abnormalities is important to provide accurate prognostic information to the referring oncologist. The purpose of this study was to use CT-guided percutaneous fine-needle aspiration bone biopsy (CT-guided FNA) of MR...
متن کاملLYMPHOID NEOPLASIA e-Blood Prediction of cytogenetic abnormalities with gene expression profiles
Cytogenetic abnormalities are important clinical parameters in various types of cancer, including multiple myeloma. We developed a model to predict cytogenetic abnormalities in patients with multiple myeloma using gene expression profiling and validated it by different cytogenetic techniques. The model has an accuracy rate up to 0.89. These results provide proof of concept for the hypothesis th...
متن کاملPrediction of cytogenetic abnormalities with gene expression profiles.
Cytogenetic abnormalities are important clinical parameters in various types of cancer, including multiple myeloma. We developed a model to predict cytogenetic abnormalities in patients with multiple myeloma using gene expression profiling and validated it by different cytogenetic techniques. The model has an accuracy rate up to 0.89. These results provide proof of concept for the hypothesis th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Blood
دوره 42 2 شماره
صفحات -
تاریخ انتشار 1973